@cmicomms.bsky.social📣 New #Communicable drops Mon 19 Oct!
Emily McDonald and Angela Huttner sit down for another Quarterly catch-up, discussing four recent RCTs across different patient populations and infections, and what the findings mean for clinical practice.
@lancetmicrobe.bsky.socialNew research article
Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus #vaccine in children aged 6–18 months by baseline serostatus
@andreaprinzi.bsky.social1/Today in #TheScienceImReading:
A great paper in Critical Care that proposes an operational framework for assessing treatment outcomes in critically ill patients with nosocomial pneumonia.
@uclapathology.bsky.socialWe are pleased to announce the appointment of Dr. Suki Chandrasekaran as Director of the UCLA Bacteriology and Antimicrobial Susceptibility Testing Laboratory!
Please join us in congratulating Dr. Chandrasekaran on her new leadership role!
@cmijournal.bsky.socialOriginal article evaluating whether early antifungal prophylaxis reduces the incidence of influenza-associated pulmonary aspergillosis (IAPA) in critically ill adults with influenza: www.clinicalmicrobiologyandinfection.org/article/S119...
@lancetmicrobe.bsky.socialNew personal view article
The future of #cholera genomics through the lens of clinical, public health, and research practitioners in Africa
@lancetmicrobe.bsky.socialNew review article
Role of the #urobiome in urinary tract infections: current knowledge and research prospects
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #UTIsky #microbiome #OpenAccess #OA
@lancetmicrobe.bsky.socialNew research article
Regional expansion and adaptive evolution of multidrug-resistant #Candida tropicalis in China: a retrospective, multicentre, genomic study
🧫 Mycoplasma & Ureaplasma are not one resistance phenotype.
🇮🇹 5-year data:
Ureaplasma spp. → ciprofloxacin R 39.5%
M. hominis → azithromycin R 60.5%
Species identification matters.
📄 doi.org/10.1089/mdr....
#IDSky #AMR #ClinMicro #MedSky
@cmijournal.bsky.socialA systematic review and meta-analysis comparing shorter-course (2∼5 days) vs. longer-course (≥7 days) antibiotic therapy for children with acute uncomplicated UTIs: www.clinicalmicrobiologyandinfection.org/article/S119... #IDSky #clinmicro #MedSky
@cmicomms.bsky.social🎙️ Just published Communicable E64: Getting micro on macrolides for community-acquired pneumonia
Hosted by Marc Bonten & Emily McDonald with invited guests Valentijn Schweitzer & Sylvain Lother 🌟
Listen on #Communicable: https://share.transistor.fm/s/deec5589
@lancetmicrobe.bsky.socialOur October issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #AMR #influenza #Streptococcus #Shigella #melioidosis #tuberculosis
@lancetmicrobe.bsky.socialNew research article
Host and environmental factors associated with upper respiratory tract mycobiota in healthy individuals: a cross-sectional observational study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #MycoSky #microbiome #mycobiome #OpenAccess #OA
@lancetmicrobe.bsky.socialNew personal view article
Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut #microbiome on #cancer development
@cmicomms.bsky.social📣 New #Communicable drops Mon 05 Oct!
Marc Bonten & Emily McDonald are joined by Valentijn Schweitzer & Sylvain Lother to discuss the use of macrolides in community-acquired pneumonia and how the available evidence informs clinical practice. Tune in!
@cmicomms.bsky.social📣 More evidence that less is probably more:
During a global shortage of #bloodculture bottles, Japanese hospitals reduced the number of sets drawn per patient.
Contamination rates went down, while detection rates of real pathogens did not.
@lancetmicrobe.bsky.socialNew research article
A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials
@lancetmicrobe.bsky.socialNew review article
#MERS-CoV in Africa: a #OneHealth review of the silent reservoir
@lancetmicrobe.bsky.socialNew research article
Epidemiology and phylogenomic characterisation of the 2025 #Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study
@lancetmicrobe.bsky.socialNew research article
Evaluation of the laboratory assessment process for A Clinically Oriented Antimicrobial Resistance Surveillance Network (ACORN-LAP) in low-income and middle-income countries
